Growth Metrics

Enanta Pharmaceuticals (ENTA) Free Cash Flow Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 66.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 137.65%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 55.25%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 55.25%
Dec 31, 2025 53.64%
Sep 30, 2025 17.98%
Jun 30, 2025 246.21%
Mar 31, 2025 47.05%
Dec 31, 2024 0.89%
Sep 30, 2024 4.52%
Jun 30, 2024 45.34%
Mar 31, 2024 -87.24%
Dec 31, 2023 33.56%
Sep 30, 2023 -43.02%
Jun 30, 2023 -14.83%
Mar 31, 2023 39.60%
Dec 31, 2022 -191.33%
Sep 30, 2022 26.17%
Jun 30, 2022 -2.22%
Mar 31, 2022 -468.40%
Dec 31, 2021 11.68%
Sep 30, 2021 -41.73%
Jun 30, 2021 -524.28%
Mar 31, 2021 -131.28%
Dec 31, 2020 -226.97%
Sep 30, 2020 -286.08%
Jun 30, 2020 -1,643.89%
Mar 31, 2020 -47.18%
Dec 31, 2019 -58.98%
Sep 30, 2019 -70.85%
Jun 30, 2019 -94.21%
Mar 31, 2019 426.71%
Dec 31, 2018 573.57%
Sep 30, 2018 -50.42%
Jun 30, 2018 194.56%
Mar 31, 2018 -143.66%
Dec 31, 2017 96.08%
Sep 30, 2017 3,558.46%
Jun 30, 2017 -103.19%
Mar 31, 2017 -141.92%
Dec 31, 2016 -92.11%
Sep 30, 2016 139.44%
Jun 30, 2016 81.34%
Mar 31, 2016 -91.35%
Dec 31, 2015 573.85%
Sep 30, 2015 26.99%
Jun 30, 2015 -142.04%
Mar 31, 2015 2,412.36%
Dec 31, 2014 0.49%
Sep 30, 2014 -100.26%
Jun 30, 2014 681.42%
Mar 31, 2014 -144.07%
Dec 31, 2013 -165.25%
Sep 30, 2013 -49.20%
Jun 30, 2013 -54.17%